Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Background
- Exhibit 1: Flu Epidemics Compared to Present 1918-Today
- Scope And Methodology
- Point of View
- Information Sources
CHAPTER TWO: 2009 SWINE INFLUENZA AND OTHER FLU EPIDEMICS
- Influenza Overview
- Overview of Virus Types
- What' s So Special About This Latest Flu?
- Flu Therapeutics
- WHO Global Influenza Preparedness Plan
CHAPTER THREE: FLU DIAGNOSTICS
- Background
- Exhbit 2: Influenza Test Innovations, 2009 (Company, Technology, Test
Details, Status)
- Immunoassays
- Rapid Testing
- Market Performance of Rapid Test
- New Entrant Possiblity
- Conclusion: Impact of Swine Flu on Rapid Testing
- Molecular Assays
- Molecular Influenza Detection Techniques
- PCR, Sequencing or Both
- Lessons and Market Impact of the H5N1 Epidemic
CHAPTER FOUR: PROGNOSIS FOR A/H1N1
- Background
- Pandemic - Where? When?
- 1976 Hsw1N1 Swine Flu Case
- Comparing Past Flu Epidemics to 2009
- International Reaction
- Swine Flu and the IVD Industry
- Origin of Flu Virus Mixes
- PCR Test Development
- Late-Breaking Research Developments
- Use of Rapid Tests in Current Epidemic
CHAPTER FIVE: COMPANIES AND PRODCUTS IMPACTED BY SWINE FLU EPIDEMIC
- Immunoassays
- 3M Medical Diagnostics
- Becton, Dickinson and Company (BD)
- Genzyme Corporation
- Inverness Medical Innovations
- Meridian Bioscience, Inc.
- Quidel Corporation
- Remel, Inc.
- Response Biomedical Corporation
- Molecular Tests
- Arbor Vita Corporation
- CombiMatrix Molecular Diagnostics (CMDX)
- Diagnostic HYBRIDS, Inc. (DHI)
- eGene Inc.
- Eiken Chemical Co., Ltd
- Life Technologies/Applied Biosystems/ Invitrogen Corporation (ABI)
- Lab21
- Laboratory Corporation of America Holdings (LabCorp)
- Luminex Corporation
- Nanogen
- Prodesse Inc.
- Qiagen N.V.
- Seegene Inc.
- Veredus Laboratories Pte
|
Related Report
|